Skip to main content

SKYRIZI risankizumab 360 mg/2.4 mL solution for injection pre-filled cartridge with on-body delivery system (2023-24)

Product name
SKYRIZI risankizumab 360 mg/2.4 mL solution for injection pre-filled cartridge with on-body delivery system
Sponsor name
Abbvie Pty Ltd
Year Range
2023-24

Help us improve the Therapeutic Goods Administration site